Lakefront Biotherapeutics NV
32.28USD
-0.0500 (-0.15%)
Fetching financial statements from SEC filings…
| In EUR M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|
| Revenue | 12 | 6 | 901 | 71 | 65 | — |
| Cost of Revenue | 9 | 5 | 0 | 11 | 5 | — |
| Gross Profit | 3 | 2 | 900 | 60 | 61 | — |
| Operating Income | -44 | -64 | 759 | -42 | -57 | — |
| Net Income | 2 | 14 | 782 | -202 | -106 | — |
| EPS (Diluted) | — | €0.22 | — | — | — | -€2.33 |
Source: Yahoo Finance (limited history)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on LKFT.